Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Elixir Bio-Tech
AddedFeb 18, 2024
UpdatedJun 18, 2026
Elixir Bio-Tech

Elixir Bio-Tech

Angel

Elixir Bio-Tech: Pioneering biotech product manufacturing.

HQ
Las Cruces, NM, US
Founded
2010
Overview
Compare
Fundraising
Employees

Elixir Bio-Tech is dedicated to pioneering biotech product manufacturing. The company focuses on developing innovative biotech solutions aimed at improving healthcare and life sciences. Their product line includes advanced biopharmaceuticals and diagnostic tools, targeting both the medical and research markets.

Elixir Bio-Tech has made significant strides in the biotech industry, earning recognition for its cutting-edge products and contributions to medical advancements. Their impact is reflected in improved patient outcomes and enhanced research capabilities.

Elixir Bio-Tech - Similar Companies

Elixir Lab logo

Elixir Lab

Elex Biotech logo

Elex Biotech

Elo Life Systems logo

Elo Life Systems

Biotech Holdings logo

Biotech Holdings

BiotechInnova logo

BiotechInnova

biotechinnova.com

Carmolex logo

Carmolex

BioAnalytics logo

BioAnalytics

BioHealthonomics logo

BioHealthonomics

Intellimedix logo

Intellimedix

Bien-Etre Labs logo

Bien-Etre Labs

Aliva Biopharmaceuticals logo

Aliva Biopharmaceuticals

Exotech Bio logo

Exotech Bio

LifeX logo

LifeX

lifex-labs.com

Control Panel logo

Control Panel

EIR Pharmaceuticals logo

EIR Pharmaceuticals

Elixir Bio-Tech - Quick Facts

Who are Elixir Bio-Tech's competitors?

Companies similar to Elixir Bio-Tech include Elixir Lab, Elex Biotech, Elo Life Systems and Biotech Holdings.

When was Elixir Bio-Tech founded?

Elixir Bio-Tech was founded in 2010.

Where is Elixir Bio-Tech's headquarters located?

Elixir Bio-Tech's headquarters is located in Las Cruces, NM, US.

When was Elixir Bio-Tech's last funding round?

Elixir Bio-Tech's most recent funding round was for $250k (USD) in April 2014.

How much has Elixir Bio-Tech raised to-date?

As of Apr 22, 2014, Elixir Bio-Tech has raised a total of $250k (USD).

How many employees does Elixir Bio-Tech have?

Elixir Bio-Tech has 5 employees as of Feb 4, 2024.

Elixir Bio-Tech - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Manufacturing
Revenue
  • Transactional
Customer
  • Enterprise
Main Product
  • Biotech Products
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software